There are many varieties of payloads available for the development of antibody drug conjugates, each has its own toxicity and profile for use in different tumours and with different targetting moeties. Abzena can synthesise chemical payloads at its Bristol, USA, plant or develop protein and DNA conjugates at its Cambridge, UK, site.
- A toolbox of payloads and production linker-payload reagents
- Custom synthesis of highly potent cytotoxic payloads
- Development of biological payloads and production of linker-payload reagents
Abzena has an inventory of highly potent cytotoxic payloads with different mechanisms of action available for use in the development of ADCs. Read more >>>
Abzena can also work on the development of many forms of payloads including proteins, DNA, RNA and variety of other fragment technologies.